Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma.
Ghirardelli P, Franceschini D, D'Aveni A, Dominici L, Ravasio A, Marzo M, Villa E, Di Noia V, Scorsetti M, Vavassori V, Ceresoli GL. Ghirardelli P, et al. Among authors: vavassori v. Lung Cancer. 2021 Feb;152:1-6. doi: 10.1016/j.lungcan.2020.11.022. Epub 2020 Nov 26. Lung Cancer. 2021. PMID: 33310300
Radiotherapy to intervention sites in mesothelioma: no more?
Ceresoli GL, Vavassori V. Ceresoli GL, et al. Among authors: vavassori v. Lancet Oncol. 2016 Aug;17(8):1025-1027. doi: 10.1016/S1470-2045(16)30132-2. Epub 2016 Jun 23. Lancet Oncol. 2016. PMID: 27345640 Free article. No abstract available.
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study.
Nicosia L, Franceschini D, Perrone-Congedi F, Molinari A, Gerardi MA, Rigo M, Mazzola R, Perna M, Scotti V, Fodor A, Iurato A, Pasqualetti F, Gadducci G, Chiesa S, Niespolo RM, Bruni A, Cappelli A, D'Angelo E, Borghetti P, Di Marzo A, Ravasio A, De Bari B, Sepulcri M, Aiello D, Mortellaro G, Sangalli C, Franceschini M, Montesi G, Aquilanti FM, Lunardi G, Valdagni R, Fazio I, Scarzello G, Vavassori V, Maranzano E, Maria Magrini S, Arcangeli S, Gambacorta MA, Valentini V, Paiar F, Ramella S, Di Muzio NG, Loi M, Jereczek-Fossa BA, Casamassima F, Osti MF, Scorsetti M, Alongi F. Nicosia L, et al. Among authors: vavassori v. Clin Transl Radiat Oncol. 2022 Dec 20;39:100568. doi: 10.1016/j.ctro.2022.100568. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2022. PMID: 36935855 Free PMC article.
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance.
Triggiani L, Mazzola R, Tomasini D, Bruni A, Alicino G, Matrone F, Bortolus R, Francolini G, Detti B, Magli A, Bonù ML, Ingrosso G, Lancia A, Trippa F, Maranzano E, Franzese C, Ghirardelli P, Vavassori V, Scorsetti M, Alongi F, Magrini SM. Triggiani L, et al. Among authors: vavassori v. Med Oncol. 2021 May 18;38(6):72. doi: 10.1007/s12032-021-01518-6. Med Oncol. 2021. PMID: 34008151 Free PMC article.
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study.
Nicosia L, Franceschini D, Perrone-Congedi F, Casamassima F, Gerardi MA, Rigo M, Mazzola R, Perna M, Scotti V, Fodor A, Iurato A, Pasqualetti F, Gadducci G, Chiesa S, Niespolo RM, Bruni A, Alicino G, Frassinelli L, Borghetti P, Di Marzo A, Ravasio A, De Bari B, Sepulcri M, Aiello D, Mortellaro G, Sangalli C, Franceschini M, Montesi G, Aquilanti FM, Lunardi G, Valdagni R, Fazio I, Scarzello G, Corti L, Vavassori V, Maranzano E, Magrini SM, Arcangeli S, Gambacorta MA, Valentini V, Paiar F, Ramella S, Di Muzio NG, Livi L, Jereczek-Fossa BA, Osti MF, Scorsetti M, Alongi F. Nicosia L, et al. Among authors: vavassori v. Radiother Oncol. 2022 Jan;166:92-99. doi: 10.1016/j.radonc.2021.10.023. Epub 2021 Nov 5. Radiother Oncol. 2022. PMID: 34748855
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience.
Francolini G, Campi R, Di Cataldo V, Detti B, Loi M, Triggiani L, La Mattina S, Borghetti P, Magrini SM, Nicosia L, Alongi F, Ghirardelli P, Vavassori V, Allegra AG, Aquilano M, Scoccimarro E, Peruzzi A, Pastina P, Visani L, Desideri I, Serni S, Meattini I, Livi L. Francolini G, et al. Among authors: vavassori v. Clin Transl Oncol. 2022 Oct;24(10):2039-2043. doi: 10.1007/s12094-022-02844-5. Epub 2022 Jun 23. Clin Transl Oncol. 2022. PMID: 35739349 Free PMC article.
98 results